Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level DNarrative ReviewPubMed
Ethical and Regulatory Considerations Related to Regenerative Medicine.
Narrative Review, published in HSS J (2025) — summary generated from the PubMed abstract.
- 2025
HSS J - Level BRandomized Controlled TrialPubMed
Cell-Based Therapies for Rotator Cuff Injuries: An Updated Review of the Literature.
Randomized Controlled Trial on Tendon Injury, Rotator Cuff, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci10 citations - Level CProspective StudyEurope PMC
Mesenchymal stem cells for subchondral bone marrow lesions: From bench to bedside
Prospective Study on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Bone Rep (2022) — summary generated from the PubMed abstract.
- 2022
Bone Rep7 citations - Level BClinical TrialEurope PMC
Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing
Clinical Trial on Immune Modulation, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
Front Cell Dev Biol36 citations - Level CCase Report / SeriesPubMed
Microfragmented Adipose Tissue With Adjuvant Platelet-Rich Plasma Combination Therapy for Partial-Thickness Supraspinatus Tear.
Case Report / Series on Rotator Cuff, Shoulder Pain, published in Cureus (2021) — summary generated from the PubMed abstract.
- 2021
Cureus2 citations - Level DNarrative ReviewEurope PMC
Stem Cell-Derived Exosomes Potential Therapeutic Roles in Cardiovascular Diseases
Narrative Review on Cardiovascular Disease, published in Front Cardiovasc Med (2021) — summary generated from the PubMed abstract.
- 2021
Front Cardiovasc Med23 citations - Level BClinical TrialEurope PMC
Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment
Clinical Trial on Immune Modulation, published in BMB Rep (2020) — summary generated from the PubMed abstract.
- 2020
BMB Rep50 citations - Level DNarrative ReviewPubMed
Bone Marrow-Derived and Adipose-Derived Mesenchymal Stem Cell Therapy in Primary Knee Osteoarthritis: A Narrative Review.
Narrative Review on Knee Osteoarthritis, Osteoarthritis, Tendon Injury, published in PM R (2019) — summary generated from the PubMed abstract.
- 2019
PM R41 citations - Level DNarrative ReviewPubMed
Orthobiologic Interventions Using Ultrasound Guidance.
Narrative Review on Osteoarthritis, Tendon Injury, Ligament Injury, published in Phys Med Rehabil Clin N Am (2016) — summary generated from the PubMed abstract.
- 2016
Phys Med Rehabil Clin N Am
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406